Type II CRISPR/Cas9 approach in the oncological therapy.

Biagioni, A; Chillà, A; Andreucci, E; Laurenzana, A; Margheri, F; Peppicelli, S; Del Rosso, M; Fibbi, G

Biagioni, A; Chillà, A; Andreucci, E; Laurenzana, A; Margheri, F; Peppicelli, S; Del Rosso, M; Fibbi, G.

Afiliação

Biagioni A; Department of Experimental and Clinical Biomedical Sciences, Section of Experimental Pathology and Oncology, University of Florence, Viale G.B. Morgagni, 50, 50134, Florence, Italy. alessio.biagioni@unifi.it.
Chillà A; Department of Experimental and Clinical Biomedical Sciences, Section of Experimental Pathology and Oncology, University of Florence, Viale G.B. Morgagni, 50, 50134, Florence, Italy. anastasiachilla@hotmail.it.
Andreucci E; Department of Experimental and Clinical Biomedical Sciences, Section of Experimental Pathology and Oncology, University of Florence, Viale G.B. Morgagni, 50, 50134, Florence, Italy.
Laurenzana A; Department of Experimental and Clinical Biomedical Sciences, Section of Experimental Pathology and Oncology, University of Florence, Viale G.B. Morgagni, 50, 50134, Florence, Italy.
Margheri F; Department of Experimental and Clinical Biomedical Sciences, Section of Experimental Pathology and Oncology, University of Florence, Viale G.B. Morgagni, 50, 50134, Florence, Italy.
Peppicelli S; Department of Experimental and Clinical Biomedical Sciences, Section of Experimental Pathology and Oncology, University of Florence, Viale G.B. Morgagni, 50, 50134, Florence, Italy.
Del Rosso M; Department of Experimental and Clinical Biomedical Sciences, Section of Experimental Pathology and Oncology, University of Florence, Viale G.B. Morgagni, 50, 50134, Florence, Italy.
Fibbi G; Department of Experimental and Clinical Biomedical Sciences, Section of Experimental Pathology and Oncology, University of Florence, Viale G.B. Morgagni, 50, 50134, Florence, Italy.

J Exp Clin Cancer Res ; 36(1): 80, 2017 06 15.

Article em En | MEDLINE | ID: mdl-28619109

Assuntos

Sistemas CRISPR-Cas; Regulação da Expressão Gênica; Terapia Genética; Neoplasias/terapia; Animais; Técnicas de Inativação de Genes; Engenharia Genética; Humanos; Neoplasias/genética

Palavras-chave

CRISPR; Gene delivery; Gene therapy; Genetic engineering; Immune therapy; Oncology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Regulação da Expressão Gênica / Sistemas CRISPR-Cas / Neoplasias Limite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google